$TRVI Cashflow Statement | Understand Stock

$TRVI

$13.35 +$0.84 (6.71%) Close

$TRVI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation
Operating lease right-of-use assets
Depreciation and amortization
Accretion of available-for-sale marketable securities, net
Write off of deferred offering costs
Accretion/accrual of term loan discounts and debt issuance costs
Other expense related to transaction with Lincoln Park Capital Fund, LLC
Loss on disposal of property, equipment and leasehold improvements
Change in fair value of term loan derivative liability
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accrued expenses and other liabilities
Accounts payable

Net cash used in operating activities
Investing activities:
Proceeds from maturities of available-for-sale marketable securities
Purchases of available-for-sale marketable securities
Purchases of property, equipment and leasehold improvements
Net cash used in investing activities
Financing activities:
Repayments of term loan
Proceeds from offering, net of commissions
Proceeds from exercises of warrants
Payments of financing costs of term loan
Proceeds from exercises of stock options
Proceeds from disgorgement of beneficial owner's short-swing profits
Proceeds from employee stock purchase plan
Payments of offering costs
Repayments of term loan, term loan final fee and prepayment premium
Payments of finance lease
Proceeds from sale of common stock and warrants in public offering and private placement, net of issuance costs
Proceeds from at-the-market sales, net of commissions
Net cash provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information:
Interest paid
State research tax credits exchanged for cash
Supplemental disclosure of non-cash financing activities:
Offering costs included in accrued expenses

Comments